Microvascular Dysfunction in Skeletal Muscle Precedes Myocardial Vascular Changes in Diabetic Cardiomyopathy: Sex-Dependent Differences.
heart failure
histopathology
microvascular dysfunction
preserved ejection fraction (HFpEF)
sex differences
skeletal muscle
type II diabetes
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
28
02
2022
accepted:
28
04
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
To uncover sex-related microvascular abnormalities that underlie the early presentation of reduced perfusion in leg skeletal muscle in a type II rat model of diabetic cardiomyopathy. Diabetes was induced using a non-obese, diet-based, low-dose streptozotocin model in adult female (18 diabetic, 9 control) and male rats (29 diabetic, 11 control). Time-course monitoring over 12 months following diabetes induction was performed using echocardiography, treadmill exercise, photoacoustic imaging, flow-mediated dilation (FMD), histopathology, and immunohistochemistry. Diabetic rats maintained normal weights. Hypertension appeared late in both diabetic males (7 months) and females (10 months), while only diabetic males had elevated cholesterol (7 months). On echocardiography, all diabetic animals maintained normal ejection fraction and exhibited diastolic dysfunction, mild systolic dysfunction, and a slightly enlarged left ventricle. Exercise tolerance declined progressively and early in males (4 months), later in females (8 months); FMD showed lower baseline femoral arterial flow but unchanged reactivity in both sexes (5 months); and photoacoustic imaging showed lower tissue oxygen saturation in the legs of diabetic males (4 months) and diabetic females (10 months). Myocardial perfusion was normal in both sexes. Histopathology at the final timepoint of Month 10 (males) and Month 12 (females) revealed that myocardial microvasculature was normal in both vessel density and structure, thus explaining normal perfusion on imaging. However, leg muscle microvasculature exhibited perivascular smooth muscle thickening around small arterioles in diabetic females and around large arterioles in diabetic males, explaining the depressed readings on photoacoustic and FMD. Histology also confirmed the absence of commonly reported HFpEF markers, including microvessel rarefaction, myocardial fibrosis, and left ventricular hypertrophy. Exercise intolerance manifesting early in the progression of diabetic cardiomyopathy can be attributed to decreased perfusion to the leg skeletal muscle due to perivascular smooth muscle thickening around small arterioles in females and large arterioles in males. This microvascular abnormality was absent in the myocardium, where perfusion levels remained normal throughout the study. We conclude that although skeletal muscle microvascular dysfunction of the vasculature presents at different levels depending on sex, it consistently presents early in both sexes prior to overt cardiac changes such as rarefaction, fibrosis, or hypertrophy.
Identifiants
pubmed: 35665251
doi: 10.3389/fcvm.2022.886687
pmc: PMC9157579
doi:
Types de publication
Journal Article
Langues
eng
Pagination
886687Informations de copyright
Copyright © 2022 Loai, Sun, Husain, Laflamme, Yeger, Nunes and Cheng.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Antioxid Redox Signal. 2010 Aug 1;13(3):269-78
pubmed: 20059401
J Hypertens. 2005 Jan;23(1):7-17
pubmed: 15643116
J Am Heart Assoc. 2016 Nov 14;5(11):
pubmed: 27930353
Cell Mol Life Sci. 2014 Feb;71(4):549-74
pubmed: 23649149
Heart Fail Rev. 2020 Mar;25(2):305-319
pubmed: 31364028
Nephrol Dial Transplant. 2009 Aug;24(8):2446-52
pubmed: 19297357
Maturitas. 2016 May;87:5-17
pubmed: 27013283
Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H733-H752
pubmed: 29351456
Eur Heart J. 2015 Jul 14;36(27):1718-27, 1727a-1727c
pubmed: 25888006
Acta Diabetol. 2020 Jun;57(6):725-732
pubmed: 32025877
Heart Fail Rev. 2014 Jan;19(1):25-33
pubmed: 23456446
J Appl Physiol (1985). 2018 May 1;124(5):1117-1139
pubmed: 29420147
Clin Nephrol. 2010 Oct;74(4):266-72
pubmed: 20875378
Endocrinology. 2012 Aug;153(8):3571-8
pubmed: 22778227
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
JACC Cardiovasc Imaging. 2022 Jun;15(6):1001-1011
pubmed: 35033490
Sci Rep. 2018 Jan 11;8(1):424
pubmed: 29323186
Front Endocrinol (Lausanne). 2018 Jan 31;9:15
pubmed: 29445357
Atherosclerosis. 2009 Dec;207(2):534-40
pubmed: 19535078
JACC Heart Fail. 2020 May;8(5):382-385
pubmed: 32241618
Med Sci Sports Exerc. 2008 Apr;40(4):612-7
pubmed: 18317387
Oxid Med Cell Longev. 2019 Apr 7;2019:6734836
pubmed: 31089412
J Physiol. 2021 Feb;599(3):981-1001
pubmed: 33347612
BMC Med. 2020 Oct 30;18(1):290
pubmed: 33121502
Front Cardiovasc Med. 2021 Jul 20;8:715400
pubmed: 34355034
Clin Biochem Rev. 2011 May;32(2):97-102
pubmed: 21611083
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
Heart Fail Rev. 2021 Nov;26(6):1333-1344
pubmed: 32219614
Cell Oncol (Dordr). 2011 Aug;34(4):343-54
pubmed: 21538025
Curr Diab Rep. 2018 Apr 18;18(6):33
pubmed: 29671082
J Diabetes Metab Disord. 2017 Nov 03;16:43
pubmed: 29142884
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H934-H949
pubmed: 30004258